This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognizing you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
A forum of leading hepatologists, endocrinologists and clinical development experts stewarding advances in science, clinical research and therapeutics for nonalcoholic fatty liver disease and steatohepatitis
RECENT EVENTS
5th NASH Roundtable™ Virtual Forum
Thursday June 16, 2022 at 11:30 AM PDT / 02:30 PM EDT
RESOURCES
Fact Sheet: NASH Roundtable™, leading clinical development experts addressing challenges in NASH drug development
View Fact Sheet »MEMBER CO-AUTHORED PUBLICATIONS
June 2022
Noninvasive Diagnosis of Nonalcoholic Steatohepatitis and Advanced Liver Fibrosis Using Machine Learning Methods: Comparative Study With Existing Quantitative Risk Scores Read More »
June 2022
Breakthroughs in therapies for NASH and remaining challenges Read More »
June 2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation Read More »
June 2022
Clinical features and outcomes of NAFLD-related hepatocellular carcinoma – Authors’ reply Read More »